Karen Miller

Imperial Chemical Industries Ltd. manufactures chemicals and paint products. Its products include coatings, adhesives, starch, and synthetic polymer. The company was founded on December 7, 1926 and is headquartered in Slough, the United Kingdom.

Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom.

Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA.

Dxterity Diagnostics, Inc. develops simple and affordable genomic testing solutions for the research, diagnostic, and therapeutic markets. It offers direct to patient platform, digital recruitment, genomic services, and QSR product development. The company was founded by Robert Terbrueggen and Jim Healy in 2006 and is headquartered in Rancho Dominguez, CA.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

HM Treasury is a British government economic and finance ministry. The company is headquartered in London, the United Kingdom.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

LGC Ltd. engages in the provision of scientific tool and solutions. It offers genomic analysis tools, drug development solutions, national laboratory, and health research program management. The company was founded in 1842 and is headquartered in Middlesex, the United Kingdom.

Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA

Accentus Medical Ltd. develops surface technology and provides solutions to the medical Industry. It provides Agluna, a surface modification technology for preventing deep-seated infection during the manufacturing of implantable medical devices. The company was founded in 2001 and is headquartered in Didcot, the United Kingdom.

Michelson Diagnostics Ltd. develops medical imaging technology solutions. The firm develops, manufactures and markets VivoSight, a point-of-care, scanning device that provides clinicians with a unique, non-invasive tool for diagnosing a variety of skin pathologies. Its VivoSight uses light to provide continuous and accurate images of the sub-surface of the skin that can be easily interpreted by a clinician to assist in diagnosis and treatment guidance. The company was founded by Jonathan Denis Holmes, Martin Johns, Gordon McKenzie, Simon Richard Hattersley and Bill Gilkes in March 2006 and is headquartered in Maidstone, the United Kingdom.

The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ.

Sport & Business Club provides sports club services. The private company is based in Aix En, France.

Part of ANGLE Plc, ANGLE Europe Ltd. is a technology platform that captures cells circulating in blood. The private company is based in Guildford, UK. ANGLE Europe was founded in 2006.

Founded in 2014, Opus 107 Ltd. is a technology-led communication services provider. The private company is based in London, UK and is part of Opus Trust Investments Ltd.

Opus Trust Investments Ltd. is a holding British company that manages and develops residential and commercial properties through its subsidiaries. The private company is based in London, UK and has subsidiaries in the United Kingdom. The company was founded in 2014.

Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN.

Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The private company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy.

Part of Jiangsu Hengrui Pharmaceuticals Co., Ltd., Luzsana Biotechnology, Inc. is a biotechnology company that develops medicines. The private company is based in Princeton, NJ.